Clinical studies have been performed on a wide range of Max Biocare products, covering many different health areas. Trials are performed to the highest clinical and regulatory standards, by researchers who are experts in their respective fields, to ensure that outcomes are measurable and meaningful.
Cognitive function
Trial topic
Omega-3 and childhood cognitive function
Trial center
The Faculty of Public Health, Mahidol University, Thailand
Objective
To evaluate the effect of Bright Kids® supplementation on cognitive function in children
Sample
School-aged children (6-12 years) willing to participate, with concurrent informed parental consent
Methods
Clinical intervention followed a three-arm, double-blind, randomised design. Participants (n = 120) were recruited and allocated to receive either placebo or the test product over a 3-month period. Efficacy was assessed by changes in their responses to tests for memory and attention span, based on non-invasive measurement of brain electrical activity.
Results
The study demonstrated that Bright Kids® intake was associated with an increase in brain electrical activity during performance of computer-based visual tests for working and long-term memory processes. The outcomes of this study were published in the journal, Foods.
Metabolism
Trial topic
Supporting healthy glucose metabolism
Trial center
The Faculty of Public Health, Mahidol University, Thailand
Objective
To investigate the efficacy of Aquielle in maintaining healthy glucose status, cardiovascular health and antioxidant status.
Sample
110 Thai subjects (aged 20-70) were included.
Methods
A randomised, double-blind, placebo-controlled study was conducted. Patients were divided into 2 groups, and each group was administered either Aquielle or placebo for 3 consecutive months (2 tablets daily).
Results
The outcomes of this trial have been published in the Journal of Natural Products. Aquielle use resulted in a beneficial effect on glucose balance, blood lipids and oxidative stress levels.
Iron deficiency
Trial topic
Dietary iron deficiency in pregnancy
Trial center
The Faculty of Public Health, Mahidol University, Thailand
Objective
To evaluate the effectiveness of ferrous bisglycinate in IronUp® for improving dietary iron deficiency in pregnant women
Sample
Pregnant women with dietary iron deficiency (20-40 years of age, 12-16 weeks)
Methods
Participants will be divided randomly into 2 groups and each will receive either IronUp® (1 capsule daily) or ferrous fumarate (1 tablet daily) for 6 months. Parameters such as haematological status, iron absorption, side effects, quality of life and general wellbeing will be monitored during and after the trial to analyse treatment effects
Results
The outcomes of this trial have been published in Nutrients. IronUp® resulted in improvements in iron absorption, iron status and blood cell counts, with lower digestive side effects than a control supplement with iron fumarate, with a 66% lower dose of iron than the control.
Articular Pain
Trial topic
Articular & arthritic pain
Trial organization
ClinMed Pharma, Poland
Objective
To assess the efficacy of Tregocel® in addition to standard of care treatment in patients with symptomatic joint aches and pains
Sample
Individuals from 40 years of age, with clinically evaluated joint aches and pains
Methods
A total of 150 participants were recruited and assigned Tregocel® (2 tablets/day) orally for 36 weeks. Efficacy was assessed by changes in ambulatory mobility as well as perceived pain, stiffness and difficulty with daily tasks. Safety was assessed by concurrent monitoring of haematological and urine parameters
Results
Tregocel® resulted in progressive reductions in pain, stiffness, mobilty and joint flexibility, an improved endurance during walking a reduced reliance on presription pain killers. The outcomes of this trial have been reported in 3 different European medical journals:
Gout
Trial topic
Relieving symptoms of occasional episodes of gout
Trial center
National Hospital for Traditional Medicine in Hanoi, Vietnam
Objective
To evaluate the safety, efficacy, and tolerability of GoutFighter for relieving symptoms of occasional episodes of gout symptoms
Sample
Adult patients were eligible to be included if they had a history of chronic gout
Methods
Clinical intervention followed a single-arm, open-label design. Participants (n = 35) received 4 tablets of GoutFighter daily over a 45-day period. Efficacy was assessed by changes in pain, swelling and blood uric acid levels, with concurrent safety and tolerability assessments
Results
GoutFighter usage resulted in statistically signifant reductions in joint pain and uric acid levels. The outcomes of this trial have been published in the Journal of Integrative & Complementary Medicine
Menopausal
Trial topic
Premenopausal and menopausal symptoms
Trial center
Medical University of Hanoi, Vietnam
Objective
To assess the efficacy and safety of PMH-Regulator® for improving premenopausal and menopausal symptoms
Sample
Healthy premenopausal and menopausal women
Methods
A total of 77 participants were administered 1 capsule of PMH-Regulator® on a daily basis for 3 consecutive months
Results
After the treatment, fewer women experienced vasomotor symptoms (i.e. hot flushes, night sweats, chills and palpitations) and neurological symptoms (i.e. headaches, concentration difficulties). In addition, improvements in urogenital-vaginal symptoms (i.e. vaginal dryness, pain during intercourse, urogenital infection) were observed following treatment and PMH-Regulator® was well tolerated
Conclusion
PMH-Regulator® is effective and safe for decreasing menopausal symptoms. For more information about the trial, please contact us here
Sexual health
Trial topic
Sexual health
Trial center
Two studies were conducted in Vietnam, at the Obstetrics & Gynaecology Hospital, Branch No. 4, of Ho Chi Minh City University of Medicines and Pharmaceuticals
Objective
To study the effects of RED-LIFE for MEN® and RED-LIFE for WOMEN® on the sexual wellbeing of males and females
Sample
Healthy males and females aged ≥ 18 years who are in stable heterosexual relationships, but without their partner in the concurrent study, with self-reported sexual dissatisfaction
Methods
We conducted two single-arm, open-label trials on males (study 1) and females (study 2) alike. Males and females consumed 2 tablets, twice per day, of either RED-LIFE for MEN® or RED-LIFE for WOMEN® respectively, over a 4-week period. Changes were assessed by the International Index of Erectile Function (IIEF) and the Female Sexual Function Index (FSFI)
Results
In both studies, improvements were observed in measures of sexual health, performance and satisfaction, and 4 weeks of treatment showed better improvements than 2 weeks treatments
Conclusion
Clinically relevant doses of RED-LIFE for MEN® and RED-LIFE for WOMEN® elicited favourable effects on male and female sexual health, performance and satisfaction. Read full of this clinical trial here.
skin health
Trial topic
Post-menopausal symptoms and skin health
Trial center
Department of Nutrition, Faculty of Public Health, Mahidol University, Thailand
Objective
To determine the effect of “Belle Dame (Supporting Womens’ Health)” on menopausal symptoms, hormonal changes and facial skin health.
Sample
Women aged 45-60 with menopausal symptoms and signs of skin aging.
Methods
Women were randomized to receive the test product or a placebo capsule for 12 week. During this time, investigators evaluated menopausal symptoms (MRS), blood reproductive hormones, facial dermatology, safety assessments (basic health indicators & blood testing including) and blood markers of oxidative stress, inflammation, cardiovascular and liver health.
Results
Compared to the placebo, use of the test product resulted in improvements in some menopause symptoms, reductions in inflammation, oxidative stress status and improvements in skin integrity. Full details of the trial have been published in the following journals:
Max Biocare brings over 20 years of experience as an international innovator in bioscience and healthcare.
We focus on creating tailored, practical solutions in the areas of:
Max Biocare Group acknowledges the Wurrunjeri Woi Wurrung and Bunurong peoples of the East Kulin nation, and the Braiakaulung people of the Gunnaikurnai Nation, on whose lands our business is conducted. We respectfully acknowledge their Ancestors and Elders, past, present and emerging.
©2022 MAX BIOCARE PTY LTD. All rights reserved